Intersection of Metastatic Cancer, Chemotherapy, and Reported Physical Abuse/Assault-Related Trauma: A Nationwide Analysis
Clinical Medicine & Research · 2025
DOI: 10.3121/cmr.2025.1989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine & Research, 2025. Verfasst von Abdul R Shour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Essentia Institute of Rural Health, Essentia, Duluth, MN, USA. Hauptthemen laut MEDLINE: Neoplasms, Physical Abuse, Wounds and Injuries, Antineoplastic Agents. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Purpose: We explored the complex relationship between the presence of metastatic cancer and undergoing cancer chemotherapy in adults with moderate to severe trauma and risk of reported physical abuse/assault-related trauma as defined in the American College of Surgeons Trauma Quality Programs Participant (ACS-TQP) dataset. We analyzed how these specific health conditions are associated with vulnerability to assault-related trauma, addressing a significant knowledge gap in existing literature.
Methods
We utilized retrospective data from the ACS-TQP from 2017-2019 (N=27,531). The outcome was the report of physical abuse/assault-related trauma (no/yes). We focused on adults (aged ≥ 18 years) diagnosed with moderate to severe physical trauma (Injury Severity Scale: 9-75) who either had metastatic cancer (exposure) or were currently receiving chemotherapy (intervention), adjusting for predisposing factors and need for care factors based on Anderson's Model of Health Service Utilization. We used descriptive statistics, Fisher's exact test, chi-square analysis, and logistic regression using Stata.v18, with a statistical significance of P≤0.05.
Results
We found 0.19% of 27,531 overall patients reported assault-related trauma, with 16,261 (0.16%) among those with moderate to severe trauma. Among these, a substantial majority with metastatic cancer reported assault-related trauma compared to those without metastatic cancer (84.62% vs. 15.38%; P value: 0.040). Patients receiving chemotherapy reported less frequent assault-related trauma than those not receiving it (26.92% vs. 73.08%; P value = 0.045). In the adjusted model, patients with metastatic cancer had significantly higher odds of reporting assault-related trauma than those without metastatic cancer (OR:7.847; 95% CI: 1.021-60.337; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Essentia Institute of Rural Health, Essentia, Duluth, MN, USA.
- Center for Clinical Epidemiology and Public Health, Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI, USA.
- Office of Research and Sponsored Programs, Marshfield Clinic Health System, Marshfield, WI, USA.
- Department of General Surgery, Marshfield Medical Center, Marshfield Clinic Health System, Marshfield, WI, USA.
- Cancer Care & Research Center, Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI, USA onitilo.adedayo@marshfieldclinic.org.
- Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Zitieren
APA
Shour, A. R., Rhodes, H. X., Puthoff, D., Sharma, R., & Onitilo, A. A. (2025). Intersection of Metastatic Cancer, Chemotherapy, and Reported Physical Abuse/Assault-Related Trauma: A Nationwide Analysis. Clinical Medicine & Research. https://doi.org/10.3121/cmr.2025.1989
Vancouver
Shour AR, Rhodes HX, Puthoff D, Sharma R, Onitilo AA. Intersection of Metastatic Cancer, Chemotherapy, and Reported Physical Abuse/Assault-Related Trauma: A Nationwide Analysis. Clinical Medicine & Research. 2025. doi:10.3121/cmr.2025.1989
BibTeX
@article{Shour2025,
author = {Shour, Abdul R and Rhodes, Heather X and Puthoff, David and Sharma, Rohit and Onitilo, Adedayo A},
title = {Intersection of Metastatic Cancer, Chemotherapy, and Reported Physical Abuse/Assault-Related Trauma: A Nationwide Analysis},
journal = {Clinical Medicine & Research},
year = {2025},
doi = {10.3121/cmr.2025.1989}
}
EUVIMED